甲状腺功能减退与全因及心血管死亡风险:中国成人回顾性队列研究
该回顾性队列纳入2017至2022年中国北方70,276名25-84岁体检成人,中位随访5.1年。显性甲减与全因死亡(HR 2.01)和心血管死亡(HR 2.70)风险升高相关,合并糖尿病者关联更强;亚临床甲减仅在50岁以下人群中与全因死亡风险升高相关。
要点
- 显性甲减增加全因死亡(HR 2.01)和心血管死亡(HR 2.70)风险。
- 合并糖尿病的显性甲减患者全因死亡风险更高(HR 5.45)。
- 亚临床甲减仅在50岁以下成人中与全因死亡风险升高相关(HR 3.28)。
核心结论
- 显性甲减与全因及心血管死亡风险升高相关,尤其在合并糖尿病人群中关联更强。
- 亚临床甲减仅在较年轻成人中与全因死亡风险升高相关,即使TSH轻度升高。
研究设计与样本
- 回顾性队列研究,纳入70,276名25-84岁在中国北方某大型医疗中心进行常规健康体检的成人。
- 甲状腺功能分为甲状腺功能正常、显性甲减和亚临床甲减,通过国家死亡登记获取死亡数据。
- 采用病因特异性Cox比例风险模型估计全因和心血管死亡的风险比(HR)。
主要发现
- 中位随访5.1年(四分位距3.6-6.0),共发生359例死亡。
- 显性甲减与全因死亡(HR 2.01;CI 1.17-3.45)和心血管死亡(HR 2.70;CI 1.18-6.19)风险升高相关。
- 合并糖尿病者中显性甲减与全因死亡的关联(HR 5.45;CI 2.46-12.07)强于无糖尿病者(HR 1.19;CI 0.56-2.54)(交互作用P=0.045)。
- 50岁以下参与者中亚临床甲减与全因死亡风险升高相关(HR 3.28;CI 1.31-8.23),包括TSH<10 mIU/L者(HR 3.36;CI 1.34-8.43)。
- 50-69岁(HR 0.32;CI 0.08-1.31)和70岁及以上(HR 1.00;CI 0.51-1.98)参与者中亚临床甲减与全因死亡无显著关联(交互作用P=0.022)。
关键数值与推荐
- 年龄亚组交互作用P=0.022。
临床怎么用
- 对显性甲减患者,尤其合并糖尿病者,应关注死亡风险升高并积极管理。
- 对50岁以下亚临床甲减患者,即使TSH轻度升高(<10 mIU/L),也需警惕全因死亡风险增加。
- 对50岁以上亚临床甲减患者,死亡风险未见显著升高,临床决策需个体化。
局限性
- 回顾性队列设计可能存在残余混杂。
- 随访时间中位数5.1年,死亡事件数相对较少。
- 研究对象为中国北方体检人群,结果外推需谨慎。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Background: The association between hypothyroidism and mortality remains inconsistent across studies. We evaluated the associations of overt and subclinical hypothyroidism with all-cause and cardiovascular mortality in a large Chinese cohort. Methods: This retrospective cohort study included 70,276 adults aged 25 to 84 years who underwent routine health examinations at a large medical center in northern China between January 1, 2017, and December 31, 2022. Thyroid function was categorized as euthyroidism, overt hypothyroidism, or subclinical hypothyroidism. Mortality data were obtained through linkage with national death registries. Cause-specific Cox proportional hazards models were used to estimate hazard ratios (HRs) for all-cause and cardiovascular mortality. Subgroup analyses were conducted by age and diabetes status. Results: Among 70,276 participants, 853 (1.2%) had overt hypothyroidism, and 2436 (3.5%) had subclinical hypothyroidism. During a median follow-up of 5.1 years (interquartile range, 3.6-6.0), 359 deaths occurred. Compared with individuals with euthyroidism, overt hypothyroidism was associated with increased all-cause (HR, 2.01; confidence interval [CI], 1.17-3.45) and cardiovascular mortality (HR, 2.70; CI, 1.18-6.19). Among individuals with diabetes, overt hypothyroidism showed a stronger association with all-cause mortality (HR, 5.45; CI, 2.46-12.07) than among those without diabetes (HR, 1.19; CI, 0.56-2.54) (p for interaction = 0.045). Subclinical hypothyroidism was associated with increased all-cause mortality among participants younger than 50 years (HR, 3.28; CI, 1.31-8.23), including those with thyrotropin (TSH) levels <10 mIU/L (HR, 3.36; CI, 1.34-8.43), but not among those aged 50 to 69 years (HR, 0.32; CI, 0.08-1.31) or 70 years or older (HR, 1.00; CI, 0.51-1.98) (p for interaction = 0.022). Conclusions: Overt hypothyroidism was associated with increased mortality, particularly in individuals with diabetes. Subclinical hypothyroidism was associated with increased mortality risk only in younger adults, even at modest TSH elevations.
引用
- Ran X, Wang N, Zhao T, et al. Hypothyroidism and Risks of All-Cause and Cardiovascular Mortality: A Retrospective Cohort Study of 70,276 Chinese Adults. Thyroid. 2025. PMID: 41213612. doi:10.1177/10507256251393523
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。